The Latest Breaking News from HIV

The biotech sector is booming, fueled by rising healthcare demands, exciting advancements in technology, and increased FDA drug approvals. Thus, investing in Illumina (ILMN), Alnylam Pharmaceuticals (ALNY), and Gilead Sciences (GILD) could be a golden opportunity for those looking to ride the wave of future breakthroughs. Read on….

At a pharmacy in Iowa, a 42-year-old Black gay man couldn’t find a medication he needed. The pharmacist, a white woman, told him they didn’t stock that medication. But while he waited to pay for his other purchases, he saw another customer place the medication he just asked for on…

Gilead stock popped Thursday after the biotech giant said its twice-yearly shot prevented 99.9% of HIV infections in a study.

Pop star recalled the late musician’s friendship during one of the hardest times of his life

As of this month, getting tested for the most common sexually transmitted infections (STIs) in France no longer requires a prescription – and if you're under 26, it's entirely free. The changes come amid a worrying rise in gonorrhoea, syphilis and other diseases passed on through sex.

The Centers for Disease Control and Prevention first used the term “AIDS” on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal of confusion over what caused the disease, who it affected…

TGA recently approved importation and supply of overseas-registered tablets to help ease the shortage

It’s a worrying question for health officials in one of the richest and most developed areas of the African continent: Why are babies being born with HIV when free medication is available to prevent mother-to-child transmission

Australian Prime Minister Anthony Albanese may be attempting to backpedal from a “hot mic” moment at the Pacific Islands Forum this week in which he joked the United States “go halvies” on a new regional policing agreement.